<DOC>
	<DOCNO>NCT00546832</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety TDS-943 ( topical diclofenac spray ) compare oral celecoxib placebo subject osteoarthritis knee . The main hypothesis TDS-943 better placebo bad celecoxib .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Topical Diclofenac Spray Osteoarthritis Knee : Trial II</brief_title>
	<detailed_description>This multicenter , outpatient , multiple-dose , placebo- active control , double-blind , double-dummy parallel group , randomize ( stratified unilateral vs. bilateral knee OA ) trial . The trial enroll subject diagnose OA knee ( confirm weight-bearing x-ray ) whose condition flare baseline . Subjects qualify enter study randomize topical TDS-943 40 mg bid , oral celecoxib 200 mg qd , placebo 3:2:2 ratio .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Males female generally good health least 40 year age Osteoarthritis ( OA ) least one knee , verify weightbearing radiograph Subject take oral NSAID analgesic least 3 day past 30 day treat knee OA pain Females pregnant lactating may become pregnant Hypersensitivity ( exacerbation asthma , rhinitis , urticaria ) sulfonamide , acetaminophen , diclofenac , celecoxib , aspirin , NSAID History myocardial infarction , congestive heart failure , stroke , coronaryartery bypass graft surgery , significant cardiovascular disease , form anticoagulation therapy lowdose aspirin ( 325 mg/day )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>